Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

951

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: fesoterodine fumarate
DRUG: Placebo
DRUG: fesoterodine fumarate

Sponsor

Pfizer